BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4544961)

  • 1. The foveal spectral thresholds in acquired dyschromatopsia.
    Zanen J
    Mod Probl Ophthalmol; 1972; 11():213-8. PubMed ID: 4544961
    [No Abstract]   [Full Text] [Related]  

  • 2. Foveal spectral thresholds in ambiguous dyschromatopsia.
    Zanen J
    Mod Probl Ophthalmol; 1974; 13(0):176-9. PubMed ID: 4548131
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative assessment of acquired colour vision deficiency in maculopathy.
    Lagerlöf O
    Mod Probl Ophthalmol; 1978; 19():276-80. PubMed ID: 310045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Boynton's method in acquired dyschromatopsia. I: Pathology of the chromatic components].
    Lanthony P
    Bull Soc Ophtalmol Fr; 1980 Mar; 80(3):235-7. PubMed ID: 6965893
    [No Abstract]   [Full Text] [Related]  

  • 5. The Pickford-Nicolson anomaloscope as a test for acquired dyschromatopsias.
    Lakowski R
    Mod Probl Ophthalmol; 1972; 11():25-33. PubMed ID: 4544964
    [No Abstract]   [Full Text] [Related]  

  • 6. The AN-59 anomaloscope in the research of acquired colour vision deficiencies.
    Mailáth L
    Mod Probl Ophthalmol; 1972; 11():34-9. PubMed ID: 4544966
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of the three color vision-mechanisms on the spectral sensitivity of the fovea.
    Marré E; Marré M
    Mod Probl Ophthalmol; 1972; 11():219-23. PubMed ID: 4362471
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired 'tritan' deficiencies in macular pathology.
    Moreland JD; Maione M; Carta F; Scoccianti L
    Mod Probl Ophthalmol; 1978; 19():270-5. PubMed ID: 310044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular color vision defects: specialized psychophysical testing in acquired and hereditary chorioretinal diseases.
    Pokorny J; Smith VC; Ernest JT
    Int Ophthalmol Clin; 1980; 20(1):53-81. PubMed ID: 6967472
    [No Abstract]   [Full Text] [Related]  

  • 10. Central scotometric plates (Umazume-Ohta) utilizing color confusion resulting from an acquired anomalous color vision.
    Ota Y
    Mod Probl Ophthalmol; 1972; 11():40-8. PubMed ID: 4544967
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical examination of the three color vision mechanisms in acquired color vision defects.
    Marré M
    Mod Probl Ophthalmol; 1972; 11():224-7. PubMed ID: 4544962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquired color perception disorders in diseases of the optic nerve and the macula diagnosed with the color spot method of Trendelenburg].
    Köhler U
    Klin Monbl Augenheilkd; 1968; 152(4):578-84. PubMed ID: 5303179
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-colour threshold in static perimetry.
    Greve EL; Verduin WM; Ledeboer M
    Mod Probl Ophthalmol; 1974; 13(0):113-8. PubMed ID: 4548123
    [No Abstract]   [Full Text] [Related]  

  • 14. Unilateral colour vision defect resembling tritanopia.
    Ohba N; Tanino T
    Mod Probl Ophthalmol; 1976; 17():331-5. PubMed ID: 1085887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oedematous maculopathies and colour sense.
    Legras M; Coscas G
    Mod Probl Ophthalmol; 1972; 11():111-6. PubMed ID: 4544946
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectral and visual deficits associated with laser irradiation.
    Zwick H; Bedell RB; Bloom K
    Mod Probl Ophthalmol; 1974; 13(0):299-306. PubMed ID: 4548147
    [No Abstract]   [Full Text] [Related]  

  • 18. Reflections, old and new, concerning acquired defects of color vision.
    Linksz A
    Surv Ophthalmol; 1973; 17(4):229-40. PubMed ID: 4606997
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acquired colour defects by F.M. 100 Hue test.
    Sharma RG; Mishra YC; Verma GL; Goswami U
    Indian J Ophthalmol; 1982 Jul; 30(4):371-3. PubMed ID: 6984695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.